Yasunori Funabashi

Title: Yasunori Funabashi: Innovator in Erythromycin Derivatives

Introduction

Yasunori Funabashi is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of erythromycin derivatives. With a total of 3 patents to his name, his work focuses on enhancing gastrointestinal function through innovative compounds.

Latest Patents

Funabashi's latest patents include the development of 15-hydroxy 6,9-hemiacetal erythromycin compounds. These patents disclose a structurally novel 6,9-hemiacetal-erythromycin derivative that possesses a hydroxyl group at either the 14- or 15-positions. This compound is noted for its excellent gastrointestinal function promoting effect and low toxicity. Additionally, he has outlined a process for preparing this derivative by reacting it with an organism-derived oxidase. Furthermore, a gastrointestinal function promoting agent containing this derivative has also been developed.

Career Highlights

Throughout his career, Yasunori Funabashi has worked with prominent companies such as Takeda Chemical Industries, Ltd. and Kitasato Kenkyushio. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations.

Collaborations

Funabashi has collaborated with notable colleagues, including Setsuo Harada and Nobuhiro Inatomi. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Yasunori Funabashi's contributions to the field of erythromycin derivatives highlight his innovative spirit and dedication to improving gastrointestinal health. His patents reflect a commitment to creating effective and safe pharmaceutical solutions.